Seeking co-operation in the production of rifamycin S-Na salt
Release time: 2011-09-22
Rifamycin S-Na Salt is a pharmaceutical intermediate for the production of rifampicin series products such as rifampicin, rifamycin sodium, rifapentine, rifaximin, rifabutin, etc. Rifamycin S-Na Salt is produced by Nocardia Mediterranea fermentation to generate rifamycin SV, and finished product rifamycin S-Na Salt is obtained by oxidisation, purification, and salt formation. At present, tuberculosis is coming back in the world, rifampicin, rifapentine, rifamycin sodium, and other products are in short supply and the price is rising. Zhengzhou People's Pharmaceutical Company mainly produces rifampicin, rifamycin sodium and other rifamycin series products, the demand for rifamycin S-Na salt is larger, before there is a production base of rifamycin S-Na salt.
Korean health authorities had said that no triple infections of MERS have been found worldwide, expressing optimism about controlling the spread of MERS. But the discovery of instances of thrice-infected people has shattered that preconception. Why are cases of triple infections so important? If MERS only occurs up to the second infection, that is, if only the first MERS infected person, A, is able to spread the MERS virus to the outside world, and if all the infected people get the virus from A (which is what happened up to the first day), then the path of MERS transmission can be "cut off" by tracking down and quarantining all the people who have had close contacts with A. MERS transmission path.Learn more